Treatment with glutamine is associated with down-regulation of Toll-like receptor-4 and myeloid differentiation factor 88 expression and decrease in intestinal mucosal injury caused by lipopolysaccharide endotoxaemia in a rat

Clinical and Experimental Immunology

Volumn 151, Issue 2, 2008, Pages 341-347

  Kessel, A ^a,c   Toubi, E ^a   Pavlotzky, E ^a   Mogilner, J ^a   Coran, A G ^b   Lurie, M ^a   Karry, R ^a   Sukhotnik, I ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b UNIVERSITY OF MICHIGAN   (United States)

^c BNAI ZION MEDICAL CENTER   (Israel)

Author keywords

Endotoxaemia; Glutamine; Lipopolysaccharide; Mucosal injury; MyD88; Toll like receptor 4

Indexed keywords

DNA; GLUTAMINE; LIPOPOLYSACCHARIDE; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; SODIUM CHLORIDE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENDOTOXEMIA; GENE EXPRESSION REGULATION; ILEUM; INTESTINE CELL; INTESTINE INJURY; INTESTINE MUCOSA; JEJUNUM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; DOWN-REGULATION; ENDOTOXEMIA; GLUTAMINE; INTESTINAL MUCOSA; INTESTINE, SMALL; LIPOPOLYSACCHARIDES; MALE; MYELOID DIFFERENTIATION FACTOR 88; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TNF RECEPTOR-ASSOCIATED FACTOR 6; TOLL-LIKE RECEPTOR 4;

EID: 37849005621     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2007.03571.x     Document Type: Article

References (30)

1. Medzhitov R. Toll-like receptors and innate immunity. Nature reviews. Immunology 2001 1 : 135 45.
2. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004 4 : 499 511.
3. Poltorak A, He X, Smirnova I et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998 282 : 2085 8.
4. Beutler B. Endotoxin, Toll-like receptor 4, and the afferent limb of innate immunity. Curr Opin Microbiol 2000 3 : 23 8.
5. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997 388 : 394 7.
6. Deitch EA. The role of intestinal barrier failure and bacterial translocation in the development of systemic infection and multiple organ failure. Arch Surg 1991 125 : 403 9.
7. Sukhotnik I, Mogilner J, Krausz MM et al. Oral arginine reduces gut mucosal injury caused by lipopolysaccharide endotoxemia in a rat. J Surg Res 2004 122 : 256 62.
8. Lacey JM, Wilmore DW. Is glutamine a conditional essential amino-acid? Nutr Rev 1990 48 : 297 309.
9. Roth E, Funovics J, Mühlbacher F et al. Metabolic disorder in severe abdominal sepsis: glutamine deficiency in skeletal muscle. Clin Nutr 1982 1 : 25 41.
10. Gamrin L, Essen P, Forsberg AM et al. A descriptive study of skeletal muscle metabolism in critically ill patients: free amino acids, energy-rich phosphates, protein, nucleic acids, fat, water, and electrolytes. Crit Care Med 1996 24 : 575 83.
11. Houdijk AP, Rijnsburger ER, Jansen J et al. Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet 1998 352 : 772 6.
12. Novak F, Heyland DK, Avenell A et al. Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med 2002 30 : 2022 9.
13. Tremel H, Kienle B, Weilemann LS et al. Glutamine dipeptide-supplemented parenteral nutrition maintains intestinal function in the critically ill. Gastroenterology 1994 107 : 1595 601.
14. Zapata-Sirvent RL, Hansbrough JF, Ohara MM et al. Bacterial translocation in burned mice after administration of various diets including fiber- and glutamine-enriched enteral formulas. Crit Care Med 1994 22 : 690 6.
15. Preiser JC, Wernerman J. Glutamine, a life-saving nutrient, but why? Crit Care Med 2003 31 : 2555 6.
16. Uehara K, Takahashi T, Fujii H et al. The lower intestinal tract-specific induction of heme oxygenase-1 by glutamine protects against endotoxemic intestinal injury. Crit Care Med 2005 33 : 381 90.
17. Sukhotnik I, Agam M, Shamir R et al. Oral glutamine prevents gut mucosal injury and improves mucosal recovery following lipopolysaccharide endotoxemia in a rat. J Surg Res 2007 143 : 379 84.
18. Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 1993 15 : 532 7.
19. Hecht G. Innate mechanisms of epithelial host defense: spotlight on intestine. Am J Physiol 1999 277 : C351.
20. Kim J, Eckmann ML, Savidge TC, Lowe DC, Witthoft T, Kagnoff MF. Apoptosis of human intestinal epithelial cells after bacterial invasion. J Clin Invest 1998 102 : 1815 23.
21. Cario E, Rosenberg IM, Brandwein SL, Beck PL, Reinecker HC, Podolsky DK. Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J Immunol 2000 164 : 966 72.
22. Zhang FX, Kirschning CJ, Mancinelli R et al. Bacterial lipopolysaccharide activates nuclear factor-κB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes. J Biol Chem 1999 274 : 7611 4.
23. Muzio M, Bosisio D, Polentarutti N et al. Differential expression and regulation of Toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J Immunol 2000 164 : 5998 6004.
24. Poltorak A, He X, Smirnova I et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998 282 : 2085 8.
25. Qureshi S, Lariviere TL, Leveque G et al. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med 1999 189 : 615 25.
26. Hoshino K, Takeuchi O, Kawai T et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the lps gene product. J Immunol 1999 162 : 3749 52.
27. Medvedev AE, Kopydlowski KM, Vogel SN. Inhibition of lipopolysaccharide- induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine, and Toll-like receptor 2 and 4 gene expression. J Immunol 2000 164 : 5564 74.
28. Abreu MT, Vora P, Faure E, Thomas LS, Arnold ET, Aarditi M. Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J Immunol 2001 167 : 1609 16.
29. Bosisio D, Polentarutti N, Sironi M et al. Stimulation of Toll-like receptor 4 expression in human mononuclear phagocytes by interferon-gamma: a molecular basis for priming and synergism with bacterial lipopolysaccharide. Blood 2002 99 : 3427 31.
30. William DL, Ha T, Li C et al. Modulation of tissue Toll-like receptor 2 and 4 during the early phases of polymicrobial sepsis correlates with mortality. Crit Care Med 2003 31 : 1808 18.